STONE MANCZAK: Open Payments
NPI 1760223770 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $531
Food & beverage: $308Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $314 |
| ABBVIE INC. | 4 | $101 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $14 |
Products named: VRAYLAR, AUSTEDO XR, INGREZZA, AJOVY, CAPLYTA, Cologuard Collection Kit, UBRELVY, ARISTADA.
Industry payments across MI — which companies pay providers there.
